Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 58-2022

To publish the March 10, 2022 letter of the FDA OIC-Director General endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
58
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 58-2022, issued April 27, 2022, publishes a March 10, 2022 letter from the Food and Drug Administration's OIC-Director General, Dr. Oscar G. Gutierrez, Jr., endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act). Per the circular, the updated List corrects the names of certain medicines used for hypertension and COVID-19 treatment. The provided text does not reproduce the List itself or any compliance instructions.